US Women's Health Market Analysis

US Women's Health Market Analysis


$ 3999

The US Women’s Health Market is projected to grow from $16.775 Bn in 2022 to $20.922 Bn by 2030, registering a CAGR of 2.80% during the forecast period of 2022 - 2030. As more women become aware of the importance of taking care of their health and the availability of new and innovative products and technologies, the demand for women's health products and services is increasing. Some key players in the US Women's Health market include Pfizer, Merck, AbbVie, Allergan, GlaxoSmithKline, Lilly, Novo Nordisk, Roche, Sanofi, Teva, Mylan, and Actavis.

ID: IN10USPH026 CATEGORY: Pharmaceuticals GEOGRAPHY: US AUTHOR: Shivam Zalke

Buy Now

US Women’s Health Market Executive Summary

The US Women’s Health Market is projected to grow from $16.775 Bn in 2022 to $20.922 Mn by 2030, registering a CAGR of 2.80% during the forecast period of 2022 - 2030.

In 2020, US national health expenditure was seen to rise high up to 19.7% of its Gross Domestic Product (GDP) from 17.6% in 2019. According to World Health Organization (WHO) Global Health Expenditure database, US healthcare expenditure per capita raised to $10,921.01 as compared to $ 10,515.32 in 2018. Healthcare spending in the US has been growing at a faster rate than the overall economy for many years.

In recent years, the US has contributed close to half of the global total in pharmaceutical sales revenues. In 2021, five of the top ten pharmaceutical businesses worldwide were American. Pfizer has surpassed all other American companies in terms of prescription medicine sales worldwide, thanks largely to the success of its COVID-19 vaccine Comirnaty. Another American business that has made a significant impact abroad is AbbVie, whose pharmaceutical operations generated a record 55 billion dollars in revenue in 2021, mostly due to the success of its enduring best-seller Humira.

The Women's Health market in the United States is a large and rapidly growing market, driven by factors such as the increasing awareness and understanding of women's health issues, the aging of the population, and the availability of new and innovative products and technologies. The market is expected to reach a value of over $50 billion by 2026, growing at a CAGR of around 5% during the forecast period from 2021 to 2026.

The US women's health market is segmented into various categories such as contraceptives, infertility treatment, menopause, osteoporosis, and cancer. The contraceptive segment is the largest segment, followed by the menopause and infertility treatment segment.

The market is driven by factors such as the increasing awareness and understanding of women's health issues, the aging of the population, and the availability of new and innovative products and technologies. The use of contraceptives, for example, has been increasing in recent years, as more women are becoming aware of the importance of family planning and the availability of new and innovative contraceptive products.

The market is also facing some challenges such as the high cost of drugs and treatments, the lack of access to healthcare for some women, and the lack of government investment in the women's health sector. These challenges can impede market growth and access to treatment.

In summary, the US women's health market is a large and rapidly growing market, driven by factors such as the increasing awareness and understanding of women's health issues, the aging of the population, and the availability of new and innovative products and technologies. The market is expected to continue to grow in the coming years, but there are some challenges to overcome as well.

us women's health market analysis

Market Dynamics

Market Growth Drivers

The key drivers of the US Women's Health market include:

  1. Increasing awareness and understanding of women's health issues: As more women become aware of the importance of taking care of their health and the availability of new and innovative products and technologies, the demand for women's health products and services is increasing.
  2. Aging population: The aging of the population is a significant driver of the women's health market, as women are more likely to experience health issues as they get older.
  3. Government support and initiatives: Government support and initiatives, such as the Affordable Care Act (ACA) and the Women's Health Amendment, have increased access to healthcare for women and have led to increased funding for women's health research and education.
  4. Technological advancements: Advances in technology have led to the development of new and innovative products and treatments for women's health, such as hormonal contraceptives and osteoporosis drugs, which are driving the growth of the market.
  5. Increase in disposable income: The increase in disposable income of people across the US has led to an increase in the adoption of expensive treatments and drugs for women's health.
  6. Increasing prevalence of chronic diseases: The increasing prevalence of chronic diseases such as osteoporosis and cancer is also driving the growth of the women's health market.

Overall, these factors are driving the growth of the US women's health market and are expected to continue to do so in the coming years.

Competitive Landscape

Key Players

Some key players in the US Women's Health market include:

  • Pfizer
  • Merck
  • AbbVie
  • Allergan
  • GlaxoSmithKline
  • Lilly
  • Novo Nordisk
  • Roche
  • Sanofi
  • Teva
  • Mylan
  • Actavis

These companies are involved in the development, manufacturing, and distribution of various women's health products such as contraceptives, infertility treatment, menopause, osteoporosis, and cancer treatments. They also invest heavily in research and development to bring new and innovative products to the market. They also have a wide distribution network which enables them to reach most of the population, making their products widely available.

Healthcare Policies and Regulatory Landscape

In the United States, the Food and Drug Administration (FDA) is responsible for regulating and approving the use of drugs and medical devices for the treatment of women's health issues. The FDA reviews and approves new drugs and medical devices for safety and efficacy before they can be marketed and sold in the US.

The US healthcare system is a complex mix of public and private insurance, with the largest public program being Medicaid and the largest private program being employer-sponsored insurance. The government also runs Medicare, which is a federal program that provides health insurance coverage to people over 65 and some people with disabilities.

The Affordable Care Act (ACA) has had a significant impact on women's health in the US. The ACA requires insurance plans to cover certain women's health services, including contraception, without cost-sharing. This has increased access to contraceptives for many women and has helped to reduce the rate of unintended pregnancies in the US.

The US also has several laws and regulations in place to protect women's rights and access to healthcare. For example, the Pregnancy Discrimination Act prohibits discrimination on the basis of pregnancy, childbirth, or related medical conditions. Additionally, the Women's Health Amendment to the Affordable Care Act requires that certain preventative services, such as mammograms and cervical cancer screenings, be covered without cost-sharing.

The FDA also has regulations in place to ensure the safety and efficacy of drugs and medical devices used in the treatment of women's health issues. The FDA has several programs in place to review and approve new drugs and medical devices for safety and efficacy and to monitor the safety of drugs and medical devices after they have been approved and are on the market.

Overall, the US has a complex healthcare system, with a mix of public and private insurance, and a range of laws and regulations in place to protect women's rights and access to healthcare. The Affordable Care Act has had a significant impact on women's health by increasing access to contraceptives, and other laws and regulations have helped to protect women's rights and access to healthcare. The FDA also plays a significant role in ensuring the safety and efficacy of drugs and medical devices used in the treatment of women's health issues.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Women's Health Market Segmentation

By Product Type (Revenue, USD Billion):

  • Devices
  • Drugs

By Application (Revenue, USD Billion):

  • Contraceptives
  • Postmenopausal Osteoporosis
  • Hormonal Infertility
  • Menopause
  • Endometriosis
  • Polycystic Ovary Syndrome (PCOS)
  • Others

By End-Users (Revenue, USD Billion):

  • Hospitals & Clinics
  • Obstetrics & Gynaecology Centers
  • Ambulatory Surgical Centers
  • Research Institutes
  • Others

By Drug (Revenue, USD Billion):

  • EVISTA
  • XGEVA
  • Prolia
  • Mirena
  • Zometa
  • Reclast/Aclasta
  • Minastrin 24 Fe
  • NuvaRing
  • FORTEO
  • Premarin
  • ACTONEL
  • ORTHO TRI-CY LO (28)

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 18 January 2023
Updated by: Keta Vora

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up